News and Updates

It’s Autoimmune Disease Awareness Month, but what are autoimmune diseases? Good question. They occur when a person’s immune system mistakenly attacks another part of the person’s own body. This response can result in a range of diseases, depending on which parts of the body are affected. Research funded by Breakthrough T1D in the 1970s and […]

I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held February 23-26, 2020, and featured some of the most world-renowned diabetes investigators. nPOD is now the world’s largest tissue bank dedicated to the study of the human pancreas in type 1 diabetes (T1D), and the […]

Generous donation furthers Breakthrough T1D mission to treat, prevent and find cures for type 1 diabetes.

Cost for each diagnosed American is nearly $500,000.

The Breakthrough T1D International Board of Directors (IBOD) named two long-time volunteers to serve as Chair and Vice Chair when current board leaders end their two-year terms on July 1. Joseph P. Lacher, Jr., who is President and Chief Executive Officer of Kemper Corporation, will serve as Breakthrough T1D Chair, succeeding current Chair Ellen Leake. […]

Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes (ATTD), which this year took place on February 19-22 in Madrid, Spain. Many of the latest advances will be discussed, including research that Breakthrough T1D has funded to advance new breakthroughs and therapies […]

CDC report shows nearly 30% increase in T1D diagnoses, with most pronounced growth among youth of diverse populations.

Ellen Leake, Chair of the International Board of Directors

Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D) science. We also are proud that our funding has helped drive their work forward toward both curing type 1 diabetes and improving the lives of those living with the disease today. The recipient of the […]

A new study commissioned by the Breakthrough T1D T1D Fund spotlights the high economic burden of type 1 diabetes (T1D) and the tremendous value of accelerating disease-modifying therapies. The study, released today, estimates the annual cost of T1D is more than $30 billion in the United States, where 1.6 million people are living with the […]